Lilly Announces Initiation of the Observational Survey of the Epidemiology, Treatment and Care of Migraine (OVERCOME) to Advance Understanding of Burden, Impact and Epidemiology of Migraine

Print More
Eli Lilly and Company logo. (PRNewsfoto/Eli Lilly and Company)

INDIANAPOLIS, June 29, 2018 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) announced today initiation of the ObserVational Survey of the Epidemiology, tReatment and Care Of MigrainE (OVERCOME) study, which

Comments are closed.